Our research focused on aberrant #Ras and Rho small GTPase signaling with the long-term goal of developing Ras and Rho inhibitors for #cancer treatment.
RAS genes (HRAS, KRAS, and NRAS) comprise the most frequently mutated oncogene family in human cancer. With the highest RAS mutation frequencies seen with the top three causes of cancer deaths in the...
She lost her father to pancreatic cancer before she finished her graduate work. She's committed herself to help give other families new hope in the fight against this disease.
A conversation with University of North Carolina pancreatic cancer researcher, Dr. Channing Der, and his niece, Marisa Jung, a development associate at PanCAN.
On a recent Saturday morning, the Der and Cox labs at the University of North Carolina at Chapel Hill were [...] READ MORE